Opportunity
Simpler Grants.gov #PAR-25-444
NIH NCI Cancer Center Support Grants (P30) for NCI-Designated Cancer Centers
Buyer
National Institutes of Health
Posted
November 26, 2025
Respond By
September 25, 2028
Identifier
PAR-25-444
NAICS
541715
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is seeking applications for P30 Cancer Center Support Grants (CCSGs) to strengthen NCI-Designated Cancer Centers. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Cancer Centers - Eligible Applicants: - U.S.-based government entities, businesses, nonprofits, and educational institutions - Foreign organizations and non-U.S. components are not eligible - Products/Services Requested: - Funding support for Comprehensive, Clinical, and Basic Cancer Centers - Focus areas include laboratory, clinical, prevention, and population-based cancer research - Development of shared research resources and infrastructure - Requirements for minimum annual NIH cancer-related funding base - Emphasis on transdisciplinary research, collaboration with other NCI-funded programs, and dissemination of research findings - Unique/Notable Requirements: - Applicants must already have significant NIH cancer-related funding - Grants are intended to enhance institutional research capabilities and foster collaboration - No specific OEMs or vendors are mentioned, as this is a research support grant rather than a procurement of products.
Description
This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. The grants support Comprehensive, Clinical, and Basic Cancer Centers, each focusing on different aspects of cancer research including laboratory, clinical, prevention, and population-based research. The purpose is to leverage institutional cancer research capabilities, integrate research into a transdisciplinary enterprise, and serve as major sources of cancer discovery and development of effective prevention, diagnosis, and therapy approaches. Applicants must meet specific funding base requirements and foreign organizations are not eligible.